AU672607B2 - Desferrioxamine-B salts and their use as orally effective iron chelators - Google Patents

Desferrioxamine-B salts and their use as orally effective iron chelators Download PDF

Info

Publication number
AU672607B2
AU672607B2 AU42700/93A AU4270093A AU672607B2 AU 672607 B2 AU672607 B2 AU 672607B2 AU 42700/93 A AU42700/93 A AU 42700/93A AU 4270093 A AU4270093 A AU 4270093A AU 672607 B2 AU672607 B2 AU 672607B2
Authority
AU
Australia
Prior art keywords
salt
international
sulphonic acid
line
document
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU42700/93A
Other languages
English (en)
Other versions
AU4270093A (en
Inventor
Ian Francis Hassan
Nicholas Lowther
Ian Timothy William Matthews
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of AU4270093A publication Critical patent/AU4270093A/en
Application granted granted Critical
Publication of AU672607B2 publication Critical patent/AU672607B2/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG Request to Amend Deed and Register Assignors: CIBA-GEIGY AG
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU42700/93A 1992-06-03 1993-05-06 Desferrioxamine-B salts and their use as orally effective iron chelators Ceased AU672607B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9211779 1992-06-03
GB929211779A GB9211779D0 (en) 1992-06-03 1992-06-03 Amine salts
PCT/GB1993/000940 WO1993024451A1 (en) 1992-06-03 1993-05-06 Desferrioxamine-b salts and their use as orally effective iron chelators

Publications (2)

Publication Number Publication Date
AU4270093A AU4270093A (en) 1993-12-30
AU672607B2 true AU672607B2 (en) 1996-10-10

Family

ID=10716488

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42700/93A Ceased AU672607B2 (en) 1992-06-03 1993-05-06 Desferrioxamine-B salts and their use as orally effective iron chelators

Country Status (16)

Country Link
US (2) US5739167A (enExample)
EP (1) EP0643690B1 (enExample)
JP (1) JPH07507288A (enExample)
KR (1) KR950701907A (enExample)
AT (1) ATE166342T1 (enExample)
AU (1) AU672607B2 (enExample)
CA (1) CA2135394A1 (enExample)
DE (1) DE69318711T2 (enExample)
DK (1) DK0643690T3 (enExample)
ES (1) ES2117132T3 (enExample)
FI (1) FI945654A0 (enExample)
GB (1) GB9211779D0 (enExample)
NO (1) NO302749B1 (enExample)
NZ (1) NZ252738A (enExample)
TW (1) TW230203B (enExample)
WO (1) WO1993024451A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE27799A1 (es) * 1996-12-10 1999-03-18 Novartis Ag Formulaciones y formas polimorficas de desferrioxamina y su preparacion
US7045531B1 (en) 1997-03-11 2006-05-16 The General Hospital Corporation Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator
GB9727224D0 (en) * 1997-12-23 1998-02-25 Nycomed Imaging As Method
US6638711B1 (en) 1999-04-29 2003-10-28 The General Hospital Corporation Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation
US6323218B1 (en) 1998-03-11 2001-11-27 The General Hospital Corporation Agents for use in the treatment of Alzheimer's disease
GB0117645D0 (en) * 2001-07-19 2001-09-12 Isis Innovation Therapeutic stratergies for prevention and treatment of alzheimers disease
US6958161B2 (en) * 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
US8614204B2 (en) 2003-06-06 2013-12-24 Fibrogen, Inc. Enhanced erythropoiesis and iron metabolism
RU2414214C2 (ru) * 2003-06-06 2011-03-20 Фиброген, Инк. Применение стабилизаторов hif-альфа для усиления эритропоэза
US8236783B2 (en) * 2006-08-15 2012-08-07 Duke University ROS-sensitive iron chelators and methods of using the same
US7932326B2 (en) * 2008-04-16 2011-04-26 The University Of Kentucky Research Foundation Chelating compounds and immobilized tethered chelators
US9259670B2 (en) 2008-04-16 2016-02-16 The University Of Kentucky Research Foundation Flow-through filter to remove aluminum from medical solutions
US9139456B2 (en) 2008-04-16 2015-09-22 The Curators Of The University Of Missouri Chelating compounds and immobilized tethered chelators

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1996192A (en) * 1991-05-13 1992-12-30 Oral-D Substituted orally effective ion chelators related to deferoxamine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH438351A (de) * 1959-09-25 1967-06-30 Ciba Geigy Verfahren zur Herstellung neuer Wuchsstoffe
FR1898M (fr) * 1961-04-07 1963-07-08 Ciba Geigy Nouvelle substance utilisable en thérapeutique.
US3679660A (en) * 1969-06-09 1972-07-25 Agatha C Magnus Glucosamine-alkylsulfonate and process
US3652411A (en) * 1969-12-04 1972-03-28 Mobil Oil Corp Polyglycol base lubricant
US4419365A (en) * 1981-12-21 1983-12-06 Ciba-Geigy Corporation Method of treating Alzheimer's disease
US4684482A (en) * 1984-01-26 1987-08-04 Oral-D (L.P.) Orally effective ion chelators
IT1173992B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente idonei per uso farmaceutico orale
MX12394A (es) * 1987-07-23 1993-12-01 Ciba Geigy Ag Procedimiento par la obtencion de carbamatos de polietilenglicol.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1996192A (en) * 1991-05-13 1992-12-30 Oral-D Substituted orally effective ion chelators related to deferoxamine

Also Published As

Publication number Publication date
ES2117132T3 (es) 1998-08-01
CA2135394A1 (en) 1993-12-09
EP0643690B1 (en) 1998-05-20
AU4270093A (en) 1993-12-30
GB9211779D0 (en) 1992-07-15
TW230203B (enExample) 1994-09-11
DE69318711D1 (de) 1998-06-25
FI945654A7 (fi) 1994-11-30
US5739167A (en) 1998-04-14
ATE166342T1 (de) 1998-06-15
DE69318711T2 (de) 1998-11-19
DK0643690T3 (da) 1999-01-25
HK1009330A1 (en) 1999-05-28
WO1993024451A1 (en) 1993-12-09
JPH07507288A (ja) 1995-08-10
US5663201A (en) 1997-09-02
NO944617L (no) 1995-01-05
FI945654A0 (fi) 1994-11-30
NO944617D0 (no) 1994-12-01
EP0643690A1 (en) 1995-03-22
NO302749B1 (no) 1998-04-20
KR950701907A (ko) 1995-05-17
NZ252738A (en) 1996-08-27

Similar Documents

Publication Publication Date Title
AU624130B2 (en) Gabapentin monohydrate and a process for producing same
Loo et al. The antitumor agent, 1, 3-bis (2-chloroethyl)-1-nitrosourea
EP0643690B1 (en) Desferrioxamine-b salts and their use as orally effective iron chelators
US20090137670A1 (en) Amino Acid Compounds
JPH05246992A (ja) １−ヒドロキシピリド−２−オン、又はその塩から成る、患者の体内にある毒性レベルの金属を減少させるのに有効な医薬組成物
US3927216A (en) 1,2,4-Triazol E-3-carboxamides for inhibiting virus infections
Marshall Jr et al. The toxicity and absorption of 2-sulfanilamidopyridine and its soluble sodium salt
Van Hogezand et al. Disposition of disodium azodisalicylate in healthy subjects: a possible new drug for inflammatory bowel disease
US4455305A (en) Composition for the treatment of colitis ulcerosa, enteritis regionalis crohn (morbus crohn), chronic nonspecific colitis and diverticulitis and the use of salicylazobenzoic acid for the preparation of such compositions
GB1581075A (en) Radiolabeled derivatives of folic acid
JP3768231B2 (ja) 原虫性感染症治療用のアトバクオンとプログアニルとのコンビネーション
CA1196656A (en) 4-amino-hepta-5,6-dienoic acid
US3934036A (en) N-benzenesulfonyl-β-alanine hydrazide useful as an immunosuppressive agent
JPH0335010A (ja) 新規ポリスチレンアニオン交換樹脂
US4590183A (en) Gastric cytoprotection with sodium thiosulfate in oral administration of aspirin
EP0006227A1 (en) Antithrombotic pharmaceutical preparation containing 2,2'-dithiobis benzamide derivatives and new 2,2'-dithiobis benzamide derivatives
HK1009330B (en) Desferrioxamine-b salts and their use as orally effective iron chelators
US3592935A (en) Substituted benzylidene hydrazines as anti-inflammatory agents
US4029666A (en) Benzenesulfonyl-ureas and process for preparing them
US4421768A (en) Fluorinated diamino-heptene and-heptyne derivatives
US3558600A (en) Alkyl sulfate salts of 1-(p-chlorobenzhydryl)-4-methylhomopiperazines
US4585764A (en) Gastric cytoprotection with 3,3'-thiobis[propanoic acid] in oral administration of aspirin
JP3247695B2 (ja) エタノール摂取を妨げるチオカルバメートスルホキシド組成物
WO1999024072A1 (fr) Agent a liberation prolongee pour medicaments et composition pharmaceutique a liberation prolongee
SE434835B (sv) N-(1-metyl-2-pyrrolidinylmetyl)-2,3-dimetoxi-5-metylsulfamoyl-bensamid, dess framstellning och farmakologisk komposition innehallande denna nya bensamid

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired